Oncology Board Review, Second Edition

Double click on above image to view full picture

Zoom Out
Zoom In
Read a Sample Chapter

Oncology Board Review, Second Edition

SKU# 9781620701157

Editors:

  • Francis P. Worden MD
  • Rami N. Khoriaty MD
  • Erin Cobain MD
  • Alexander T. Pearson MD, PhD

Includes access to e-book and Q&A app

Supplemental Materials
$95.00

Description 

Oncology Board Review: Blueprint Study Guide and Q&A is a concise, outline-based study guide covering the topics that appear on the Medical Oncology Certification Exam. This second edition has been thoroughly revised to include new treatment regimens, clinical guidelines, and other updates impacting the field and reflected on the test.

The book includes all topics listed in the American Board of Internal Medicine (ABIM) blueprint as essential material for the Medical Oncology Certification Exam. The coverage spans all hematologic malignancies and solid tumors, beginning with the epidemiology, and followed by the etiology and risk factors of the disease, staging, signs and symptoms, diagnostic criteria, indications for treatment, prognostic factors, treatment recommendations, and special considerations. Later chapters review other major subspecialty areas found on the exam including cancer genetics and tumor biology, supportive and palliative care, bone marrow transplantation, and biostatistics. Each chapter includes key points summarized in digestible bullets for easy recall and self-assessment. And, now containing over 230 board-style questions with answers and detailed rationales, Oncology Board Review, Second Edition is the go-to, quick review for any trainee preparing for initial certification and for oncologists preparing for recertification.

New to this Edition:

  • Over 230 board-style questions and answers with rationales
  • New chapter on Bone Marrow Transplantation
  • Thoroughly updated and revised chapters with all new treatment recommendations and FDA approvals for solid tumors and hematologic malignancies included
  • Includes access to e-book and Q&A app

Product Details 

  • Publication Date May 22, 2017
  • Page Count 480
  • Product Form Paperback / softback
  • ISBN 13 9781620701157

About The Author(s) 

Professor of Medicine, and Director of the Hematology/Oncology Fellowship Program at University of Michigan Medical School in Ann Arbor, MichiganClinical Lecturer, Department of Internal Medicine, University of Michigan Medical School in Ann Arbor, Michigan

Table of Contents 

Contributors

Preface

Acknowledgments

PART I. HEMATOLOGIC MALIGNANCIES

1. Acute Leukemias and Hairy Cell Leukemia

Lyndsey N. Runaas, Rami N. Khoriaty, and Dale Bixby

2. Chronic Lymphocytic Leukemia

Erlene K. Seymour, Rami N. Khoriaty, and Dale Bixby

3. Chronic Myeloid Leukemia and Myeloproliferative Neoplasms

Brittany Siontis and Rami N. Khoriaty

4. Myelodysplastic Syndromes

Rami N. Khoriaty and Dale Bixby

5. Hodgkin Lymphoma

Darren King and Ryan A. Wilcox

6. Non-Hodgkin Lymphoma—Low Grade

Erlene K. Seymour and Tycel J. Phillips

7. Non-Hodgkin Lymphoma—High Grade

Erlene K. Seymour and Tycel J. Phillips

8. Peripheral T-Cell Lymphomas

Sumana Devata and Ryan A. Wilcox

9. Multiple Myeloma and Plasma Cell Dyscrasias

Maryann Shango and Erica Campagnaro

PART II. AERODIGESTIVE MALIGNANCIES

10. Non–Small Cell Lung Cancer

Manali Bhave and Gregory P. Kalemkerian

11. Small Cell Lung Cancer

Dana E. Angelini and Khaled A. Hassan

12. Malignant Pleural Mesothelioma

Jordan K. Schaefer and Gregory P. Kalemkerian

13. Thymoma and Thymic Carcinoma

Jordan K. Schaefer and Gregory P. Kalemkerian

14. Head and Neck Cancers and Salivary Gland Tumors

Paul L. Swiecicki and Francis P. Worden

PART III. ENDOCRINE MALIGNANCIES

15. Thyroid Cancer

Paul L. Swiecicki and Megan R. Haymart

16. Adrenocortical Carcinoma

Frank C. Cackowski and Tobias Else

17. Pheochromocytomas and Paragangliomas

Frank C. Cackowski and Tobias Else

PART IV. BREAST CANCER

18. Breast Cancer

Kunal C. Kadakia, Erin F. Cobain, and Monika Burness

PART V. GENITOURINARY MALIGNANCIES

19. Bladder Cancer

Sarah Yentz, Alon Weizer, and Ajjai Alva

20. Prostate Cancer

Zachery R. Reichert, Megan E. V. Caram, and Kathleen Ann Cooney

21. Testicular Cancer

Zachery R. Reichert and David C. Smith

22. Renal Cell Carcinoma

Benjamin Y. Scheier and Bruce Redman

PART VI. GASTROINTESTINAL MALIGNANCIES

23. Esophageal Cancer

Raymond M. Esper, Paul L. Swiecicki, and James A. Hayman

24. Gastric Cancer

David B. Zhen and Mark M. Zalupski

25. Colorectal Cancer

Maryann Shango and John C. Krauss

26. Anal Cancer

Maryann Shango and John C. Krauss

27. Pancreatic and Biliary Cancers

David B. Zhen and Mark M. Zalupski

28. Hepatocellular Carcinoma

Paul M. Corsello and Neehar D. Parikh

29. Neuroendocrine Tumors

Sarah Yentz and Vaibhav Sahai

PART VII. SARCOMA

30. Sarcoma

Elizabeth J. Davis and Rashmi Chugh

PART VIII. MELANOMA

31. Melanoma

Darren King and Christopher Lao

PART IX. CENTRAL NERVOUS SYSTEM MALIGNANCIES

32. Central Nervous System Tumors

Erin F. Cobain, Aaron Mammoser, and Larry Junck

PART X. GYNECOLOGIC MALIGNANCIES

33. Cervical, Vulvar, and Vaginal Cancers

Kari E. Hacker and Karen McLean

34. Ovarian Cancer

Lan G. Coffman and Ronald J. Buckanovich

35. Endometrial Cancer

Lan G. Coffman and Ronald J. Buckanovich

PART XI. CANCER OF UNKNOWN PRIMARY

36. Cancer of Unknown Primary

Benjamin Y. Scheier and Laurence H. Baker

PART XII. GENETICS AND TUMOR BIOLOGY

37. Genetics and Tumor Biology

Carlos J. Gallego, Jessica N. Everett, Shawna Kraft, and Elena M. Stoffel

PART XIII. SUPPORTIVE AND PALLIATIVE CARE

38. Oncologic Emergencies and Supportive Care

Angel Qin, Francis P. Worden, and Maria Silveira

PART XIV. BONE MARROW TRANSPLANTATION

39. Bone Marrow Transplant

Lyndsey N. Runaas and Mary Mansour Riwes

PART XV. BIOSTATISTICS

40. Biostatistics

Alexander T. Pearson and Emily Bellile

Index